Onconetix, Inc. (ONCO)Healthcare | Biotechnology | Cincinnati, United States | NasdaqCM
0.73 USD
-0.01
(-1.081%) ⇩
(April 20, 2026, 4 p.m.
EDT)
Short-term: ★★☆☆☆ | Long-term: ☆☆☆☆☆ | Dividends: ☆☆☆☆☆ |
Hot Take | April 19, 2026, 12:07 a.m. EDT
ONCO faces a double-edged sword of existential liquidity engineering and severe technical decay. While the reverse split and Realbotix partnership successfully engineer the share count to meet Nasdaq survival rules, the forecasting model predicts a 27.6% downside over the next 45 days, signaling that the market has likely priced in the 'jumps' of speculation only to face an imminent correction now that the reinstatement hype has faded. |
| Model | MAE |
|---|---|
| AutoTheta ✓ | 0.541998 |
| MSTL | 0.892734 |
| AutoETS | 0.917603 |
| AutoARIMA | 0.917611 |
Forecast horizon: 45 days | Selected: AutoTheta
| Forecast Reliability | |
|---|---|
| Score | 42% |
| H-stat | 20.90 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.711 |
| Excess Kurtosis | -0.58 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 0.309 |
| Revenue per Share | 4.348 |
| Market Cap | 524,733 |
| Forward P/E | -0.86 |
| Beta | 3.63 |
| Website | https://www.onconetix.com |
| Attribute | Value |
|---|---|
| 52 Week Change | -0.97080755 |
| Address1 | 201 East Fifth Street |
| Address2 | Suite 1900 |
| All Time High | 1,545,300.0 |
| All Time Low | 0.671 |
| Ask | 0.9503 |
| Ask Size | 2 |
| Average Daily Volume10 Day | 27,363,980 |
| Average Daily Volume3 Month | 5,833,350 |
| Average Volume | 5,833,350 |
| Average Volume10Days | 27,363,980 |
| Beta | 3.634 |
| Bid | 0.5724 |
| Bid Size | 2 |
| Book Value | 50.528 |
| City | Cincinnati |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 0.732 |
| Current Ratio | 0.664 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,774,915,200 |
| Day High | 0.825 |
| Day Low | 0.7227 |
| Debt To Equity | 0.309 |
| Display Name | Onconetix |
| Earnings Timestamp End | 1,756,670,400 |
| Earnings Timestamp Start | 1,756,324,800 |
| Ebitda | -6,329,686 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | 0.734 |
| Enterprise To Revenue | -5.699 |
| Enterprise Value | -4,647,146 |
| Eps Forward | -0.85 |
| Eps Trailing Twelve Months | -82.8 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 2.88378 |
| Fifty Day Average Change | -2.1517801 |
| Fifty Day Average Change Percent | -0.7461665 |
| Fifty Two Week Change Percent | -97.08076 |
| Fifty Two Week High | 74.375 |
| Fifty Two Week High Change | -73.643 |
| Fifty Two Week High Change Percent | -0.99015796 |
| Fifty Two Week Low | 0.671 |
| Fifty Two Week Low Change | 0.06099999 |
| Fifty Two Week Low Change Percent | 0.09090907 |
| Fifty Two Week Range | 0.671 - 74.375 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,645,194,600,000 |
| Float Shares | 653,838 |
| Forward Eps | -0.85 |
| Forward P E | -0.86117643 |
| Free Cashflow | -4,494,873 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 2 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.77623004 |
| Gross Profits | 632,913 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.10163 |
| Held Percent Institutions | 0.26274002 |
| Implied Shares Outstanding | 716,849 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Last Split Date | 1,774,396,800 |
| Last Split Factor | 1:5 |
| Long Business Summary | Onconetix, Inc., a biotechnology company, focuses on the research, development, and commercialization of solutions for men's health and oncology in the United States, the European Union, and Non-European Union. The company offers Proclarix, an in vitro protein-based blood diagnostic test for prostate cancer. It has a license agreement with LabCorp to develop and commercialize Proclarix and other products; and with Immunovia AB for the development, manufacturing, and commercialization of the PancreaSure test. The company was formerly known as Blue Water Biotech, Inc. and changed its name to Onconetix, Inc. in December 2023. Onconetix, Inc. was founded in 2018 and is headquartered in Cincinnati, Ohio. |
| Long Name | Onconetix, Inc. |
| Market | us_market |
| Market Cap | 524,733 |
| Market State | PRE |
| Max Age | 86,400 |
| Message Board Id | finmb_600261365 |
| Most Recent Quarter | 1,767,139,200 |
| Net Income To Common | -15,530,937 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 507,222 |
| Open | 0.74 |
| Operating Cashflow | -9,678,390 |
| Operating Margins | -4.2206297 |
| Payout Ratio | 0.0 |
| Phone | 513 620 4101 |
| Pre Market Change | -0.010100007 |
| Pre Market Change Percent | -1.3797824 |
| Pre Market Price | 0.7219 |
| Pre Market Time | 1,776,775,570 |
| Previous Close | 0.74 |
| Price Hint | 4 |
| Price To Book | 0.014487017 |
| Price To Sales Trailing12 Months | 0.64355123 |
| Profit Margins | 0.0 |
| Quick Ratio | 0.614 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | -0.008 |
| Regular Market Change Percent | -1.08108 |
| Regular Market Day High | 0.825 |
| Regular Market Day Low | 0.7227 |
| Regular Market Day Range | 0.7227 - 0.825 |
| Regular Market Open | 0.74 |
| Regular Market Previous Close | 0.74 |
| Regular Market Price | 0.732 |
| Regular Market Time | 1,776,715,200 |
| Regular Market Volume | 2,509,704 |
| Return On Assets | -0.14934 |
| Return On Equity | -1.15458 |
| Revenue Growth | -0.574 |
| Revenue Per Share | 4.348 |
| Sand P52 Week Change | 0.34445214 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 692,927 |
| Shares Percent Shares Out | 0.9813 |
| Shares Short | 680,001 |
| Shares Short Previous Month Date | 1,772,150,400 |
| Shares Short Prior Month | 7,583 |
| Short Name | Onconetix, Inc. |
| Short Percent Of Float | 0.984 |
| Short Ratio | 0.2 |
| Source Interval | 15 |
| State | OH |
| Symbol | ONCO |
| Total Cash | 5,220,654 |
| Total Cash Per Share | 7.283 |
| Total Debt | 48,774 |
| Total Revenue | 815,371 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -82.8 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 11.215695 |
| Two Hundred Day Average Change | -10.483695 |
| Two Hundred Day Average Change Percent | -0.9347343 |
| Type Disp | Equity |
| Volume | 2,509,704 |
| Website | https://www.onconetix.com |
| Zip | 45,202 |